Traws Pharma Net Income

Traws Pharma (TRAW) currently reports a net income of $-3.9B as of May 2026. That compares with $-170M in the prior-year period — down 2267.3% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Traws Pharma's net income history and peer comparisons.

Traws Pharma's net income decreased from $-170M to $-3.9B — a 2267.3% year-over-year decrease (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Traws Pharma's net income of $-3.9B is lower than the Healthcare sector average of $16B. That is roughly 124.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Traws Pharma reported $-3.9B in net income as of May 2026. That compares with $-170M in the prior-year period — down 2267.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-3.9B, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Traws Pharma, and consider following TRAW for alerts when major investors trade the stock.